Modulating the microbiome as an approach to anticancer drug development

Journal:

Proceedings of the National Academy of Sciences of the United States of America

Published:

2025-10-28

DOI:

10.1073/pnas.2417269122

Affiliations:

8

Authors:

20

Go to article

Institutions	Authors	Share
City University of Hong Kong (CityU), China	10.000000 10.000000	0.50
Nikolaev Institute of Inorganic Chemistry (NIIC), SB RAS, Russia	4.000000	0.20
N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry (NIOCH), SB RAS, Russia	2.000000	0.10
Lomonosov Moscow State University (MSU), Russia	1.000000	0.05
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry (IBCh), RAS, Russia	1.000000	0.05
GBUZ Moscow Clinical Scientific Center named after Loginov MHD (MCSC), Russia	1.000000	0.05
Queen Elizabeth Hospital, Hong Kong, China	1.000000	0.05

Interested in Clinical Sciences?